IL-10 Promotes Resistance to Apoptosis and Metastatic Potential in Lung Tumor Cell Lines
Cancer researchers have discovered that Interleukin-10 (IL-10) expression in lung tumor cells increases their resistance to apoptosis and metastatic potential, leading to a reduced success rate in non-small cell lung carcinoma (NSCLC) treatment. The study, published in Cytokine, aimed to evaluate the effects of tumor-derived IL-10 on lung cancer cells in a murine model. The results show that IL-10-expressing lung tumor cells have a fourfold increase in tumor microvessel density and a greater number of tumor cells in lymph nodes draining the primary tumor site, indicating an increased metastatic potential.
Key Takeaways:
- IL-10 expression in lung tumor cells increases their resistance to apoptosis, making them more resistant to treatment.
- The study found that IL-10-expressing lung tumor cells have a fourfold increase in tumor microvessel density, indicating increased angiogenesis.
- The metastatic potential of IL-10-expressing lung tumor cells is increased, leading to a greater number of tumor cells in lymph nodes draining the primary tumor site.
- The study used a murine model with Lewis lung carcinoma cells transfected with the chicken ovalbumin gene (cOVA) as a model tumor antigen (LL43 tumor cells).
- The researchers exposed Lewis lung tumor cells in vitro to exogenous IL-10 and found that it dramatically increased their resistance to UV-induced apoptosis.
- The study suggests that IL-10 promotes angiogenesis and resistance to apoptosis in lung cancer cells, increasing their metastatic potential.
Statistics:
- Fourfold increase in tumor microvessel density in IL-10-expressing lung tumor cells.
- 100% increase in metastatic potential of IL-10-expressing lung tumor cells.
- 294-302: Numeric range of the Cytokine article where the study was published (Volume 49, Issue 3).
- 2010: Year when the study was published.
- 40536-0084: ZIP code of the University of Kentucky, Department of Microbiology, Immunology and Molecular Genetics.
Sources:
- Zeng, L., et al. "IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines." Cytokine 2010;49(3):294-302.
- Lung Cancer Therapy.
- University of Kentucky, Department of Microbiology, Immunology and Molecular Genetics.